Related references
Note: Only part of the references are listed.Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
Xintian Xu et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
Jasper Fuk-Woo Chan et al.
EMERGING MICROBES & INFECTIONS (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment
Zhenwei Wang et al.
BIOSCIENCE TRENDS (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon et al.
NATURE (2020)
Structural basis of receptor recognition by SARS-CoV-2
Jian Shang et al.
NATURE (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Overview of therapeutic drug research for COVID-19 in China
Heng Li et al.
ACTA PHARMACOLOGICA SINICA (2020)
Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation
Jungang Chen et al.
PLOS PATHOGENS (2019)
BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia
Sandra Cuellar et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2018)
Repurposing potential of 1st generation H-1-specific antihistamines as anti-filovirus therapeutics
Adam Schafer et al.
ANTIVIRAL RESEARCH (2018)
The Antihistamine Drugs Carbinoxamine Maleate and Chlorpheniramine Maleate Exhibit Potent Antiviral Activity Against a Broad Spectrum of Influenza Viruses
Wei Xu et al.
FRONTIERS IN MICROBIOLOGY (2018)
Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion
Christopher M. Coleman et al.
JOURNAL OF VIROLOGY (2016)
Toremifene interacts with and destabilizes the Ebola virus glycoprotein
Yuguang Zhao et al.
NATURE (2016)
Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process
Cristiano Salata et al.
PATHOGENS AND DISEASE (2015)
Evaluation of Ebola Virus Inhibitors for Drug Repurposing
Peter B. Madrid et al.
ACS INFECTIOUS DISEASES (2015)
Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation
Li Yang et al.
ACTA PHARMACOLOGICA SINICA (2014)
Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
Adriaan H. de Wilde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
Julie Dyall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection
Charles J. Shoemaker et al.
PLOS ONE (2013)
The dopamine antagonist cis-flupenthixol blocks the expression of the conditioned positive but not the negative effects of cocaine in rats
Jennifer M. Wenzel et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection
Lisa M. Johansen et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV
Guangyu Zhao et al.
VIROLOGY JOURNAL (2013)
Productive Replication of Ebola Virus Is Regulated by the c-Abl1 Tyrosine Kinase
Mayra Garcia et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Variola and Monkeypox Viruses Utilize Conserved Mechanisms of Virion Motility and Release That Depend on Abl and Src Family Tyrosine Kinases
Patrick M. Reeves et al.
JOURNAL OF VIROLOGY (2011)
WSS45, a sulfated α-D-glucan, strongly interferes with Dengue 2 virus infection in vitro
Xian-kun Tong et al.
ACTA PHARMACOLOGICA SINICA (2010)
Molecular markers and targets for colorectal cancer prevention
Naveena B. Janakiram et al.
ACTA PHARMACOLOGICA SINICA (2008)
Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level
Konrad Stadler et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions
CB Coyne et al.
CELL (2006)
Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique
S Chen et al.
ACTA PHARMACOLOGICA SINICA (2005)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)